Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology
Published in: Indian Journal of Surgical Oncology 4/2017

01-12-2017 | Review Article

An Overview of the Current Management of Bilobar Colorectal Liver Metastases

Authors: Rebecca K. L. Griggs, Samir Pathak, Graeme Poston

Published in: Indian Journal of Surgical Oncology | Issue 4/2017

Login to get access

Abstract

Bilobar colorectal liver metastases (BCRLM) present a challenging scenario for liver surgeons globally. The following article aims to provide an overview of the different strategies which may be utilised in order to successfully manage advanced BCRLM.
Literature
1.
2.
3.
Haggar F, Boushey R (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 6(212):191–197CrossRef
4.
Bengmark S, Hafström L (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198–202CrossRefPubMed
5.
Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L (1987) Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg 205:264–270CrossRefPubMedCentralPubMed
6.
Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343(8910):1405–1410CrossRefPubMed
7.
8.
Lemke A, Brinkmann M, Schott T, Niehues S, Settmacher U, Neuhaus P et al (2016) Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology 240(3):736–742CrossRef
9.
Truant S, Baillet C, Deshorgue A, Leteurtre E, Hebbar M, Ernst O et al (2016) Drop of total liver function in the interstages of the new associating liver partition and portal vein ligation for staged hepatectomy technique: analysis of the “auxiliary liver” by HIDA scintigraphy. Ann Surg 26:e33–e34CrossRef
10.
Simmonds P, Primrose J, Colquitt J, Garden O, Poston G, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94(7):982–999CrossRefPubMedCentralPubMed
11.
Jarnagin W, Gonen M, Fong Y, DeMatteo R, Ben-Porat L, Little S et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406CrossRefPubMedCentralPubMed
12.
Chan K, Chiang J, Lee C, Yu M, Lee W, Chen J et al (2011) Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol 9:174CrossRefPubMedCentralPubMed
13.
Chun Y, Vauthey J (2007) Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33:S52–S58CrossRefPubMed
14.
Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8(4):347–353CrossRefPubMed
15.
Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644–657PubMedCentralPubMed
16.
Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F et al (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10(6):663–669CrossRefPubMed
17.
Jones RP and Poston GJ (2017) Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy. 68:183–196
18.
Lewandowski R, Memon K, Mulcahy M, Hickey R, Marshall K, Williams M et al (2014) Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. Eur J Nucl Med Mol Imaging 41(10):1861–1869CrossRefPubMed
19.
Tanaka K, Shimada H, Kubota K, Ueda M (2005) Effectiveness of prehepatectomy intra- arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 137(2):156–164CrossRefPubMed
20.
Gruber-Rouh T, Nagui NNN, Eichler K, Ackermann H, Zangos S, Trojan J et al (2013) Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer 134(5):1225–1231CrossRefPubMed
21.
Jones R, Malik H, Fenwick S, Terlizzo M, O’Grady E, Stremitzer S et al (2016) PARAGON II—a single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer. Eur J Surg Oncol 42(12):1866–1872CrossRefPubMed
22.
Jones R, Sutton P, Greensmith R, Santoyo-Castelazo A, Carr D, Jenkins R et al (2013) Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. Cancer Chemother Pharmacol 72(2):359–368CrossRefPubMed
23.
Jones R, Stättner S, Dunne D, O’Grady E, Smethurst A, Terlizzo M et al (2013) Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for colorectal liver metastases does not predict tumour destruction or long-term outcome. Eur J Surg Oncol 39(10):1122–1128CrossRefPubMed
24.
Jones R, Dunne D, Sutton P, Malik H, Fenwick S, Terlizzo M et al (2013) Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series. HPB 15(1):71–77CrossRefPubMed
25.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nor. J Clin Oncol 25(13):1670–1676CrossRefPubMed
26.
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat unresectable liver tumors. Ann Surg 232(6):777–785
27.
Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed
28.
Broering D, Hillert C, Krupski G, Fischer L, Mueller L, Achilles E et al (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6(6):905–913CrossRefPubMed
29.
Elias D, de Baere T, Roche A, Ducreux M, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. BJS. 86:784–788CrossRef
30.
Van Lienden K, Van Den Esschert J, de Graaf W, Bipat S, Lameris J, van Gulik T et al (2013) Portal vein embolization before liver resection: a systematic review. Cardiovasc Interv Radiol 36(1):25–34CrossRef
31.
Pearson A, Izzo F, Fleming R, Ellis L, Delrio P, Roh M et al (1999) Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178:592–599CrossRefPubMed
32.
Martin R, Scoggins C, McMasters K (2007) Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 96:481–486CrossRefPubMed
33.
Boutros C, Somasundar P, Garrean S, Saied A, Espat N (2010) Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. J Surg Oncol 19:e22–e32CrossRef
34.
Wright A, Lee F, Mahvi D (2003) Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10:275–283CrossRefPubMed
35.
Bilchik A, Wood T, Allegra D, Tsioulias G, Chung M, Rose D et al (2016) Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 135:657–664CrossRef
36.
Mima K, Beppu T, Chikamoto A, Miyamoto Y, Nakagawa S, Kuroki H et al (2013) Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol 18:847–855CrossRefPubMed
37.
Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M et al (2012) Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One 7(9):e45493CrossRefPubMedCentralPubMed
38.
He N, Jin Q, Wang D, Yang Y, Liu Y, Wang G et al (2016) Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technol Med Sci 36(4):514–518CrossRefPubMed
39.
Philips P, Groeschl RT, Hanna EM, Swan RZ, Turaga KK, Martinie JB et al (2016) Single-stage resection and microwave ablation for bilobar colorectal liver metastases. BJS 103(8):1048–1054CrossRef
40.
Nicholl M, Bilchik A (2008) Thermal ablation of hepatic malignancy: useful but still not optimal. Eur J Surg Oncol 34:318–323CrossRefPubMed
41.
Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik T, Choti M (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1261–1268CrossRefPubMed
42.
Mentha G, Terraz S, Morel P, Andres A, Giostra E, Roth A et al (2009) Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 96:95–103CrossRefPubMed
43.
Imai K, Benitez C, Allard M, Vibert E, SaCunha A, Cherqui D et al (2015) Failure to achieve a 2-stage hepatectomy for colorectal liver metastases: how to prevent it? Ann Surg 262(5):772–779CrossRefPubMed
44.
Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P et al (2011) Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg 98(10):1463–1475CrossRefPubMed
45.
Lam V, Laurence J, Johnston E, Hollands M, Pleass H, Richardson A (2013) A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB 15(7):483–491CrossRefPubMed
46.
Fuks D, Nomi T, Ogiso S, Gelli M, Velayutham V, Conrad C et al (2015) Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases. BJS 102:1684–1690CrossRef
47.
Evrard S, Poston G, Kissmeyer-nielsen P, Diallo A, Sta S, Fenwick S et al (2014) Combined ablation and resection (CARe ) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One 9(12):e114404CrossRefPubMedCentralPubMed
48.
Baumgart J, Farkas SA, Fichtner-feigl S, Lorf T (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):24–26
49.
Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T et al (2016) Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases—intermediate oncological results. Eur J Surg Oncol 42(4):531–537CrossRefPubMed
50.
Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M et al (2015) Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy. Ann Surg Oncol 22(6):1933–1942CrossRefPubMed
51.
Jackson JE, Tait P (2015) Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration. Ann Surg 261(2):2014–2015
52.
Jiao LR, Hakim DN, Gall TMH, Fajardo A, Pencavel TD, Fan R et al (2016) How we do it a totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency ( radiofrequency assisted liver partition with portal vein ligation ) for staged liver resection. Hepatobiliary Surg Nutr 5(3):382–387CrossRefPubMedCentralPubMed
53.
Stavrou GA, Papalampros A, Donati M, Oldhafer KJ (2016) Synchronous liver metastases in colon cancer: step one of ALPPS and simultaneous right hemicolectomy. Int Hepato-Pancreato-Biliary Assoc 18:e723CrossRef
54.
Petrou A, Moris D, Kountourakis P, Fard-Aghaie M, Neofytou K, Felekouras E, Papalampros A (2016) The ALPPS procedure as a novel “ liver-first ” approach in treating liver metastases of colon cancer : the first experience in Greek Cypriot area. World J Surg Oncol 14:67
55.
Hagness M, Foss A, Line P, Scholz T, Jørgensen P, Fosby B et al (2013) Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 257(5):800–806CrossRefPubMed
56.
Dueland S, Guren T, Hagness M, Glimelius B, Line P, Pfeiffer P et al (2015) Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg 261(5):956–960CrossRefPubMed
57.
Dueland S, Hagness M, Line P, Guren T, Tveit K, Foss A (2015) Liver transplantation an option in colorectal cancer patients with nonresectable liver metastases and progression on all lines of standard chemotherapy? Ann Surg Oncol 22(7):2195–2200CrossRefPubMed
58.
Hrehoreţ D, Alexandrescu S, Braşoveanu V, Grigorie R, Zielinski C, Popescu I (2013) Liver transplantation in a patient with unresectable colorectal liver metastases—a case report. Chirurgia 108(5):719–724PubMed
Metadata
Title
An Overview of the Current Management of Bilobar Colorectal Liver Metastases
Authors
Rebecca K. L. Griggs
Samir Pathak
Graeme Poston
Publication date
01-12-2017
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 4/2017
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-017-0686-6

Other articles of this Issue 4/2017

Indian Journal of Surgical Oncology 4/2017 Go to the issue

Review Article

Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer

Original Article

Ovarian Metastases of Colorectal Origin: Treatment Patterns and Factors Affecting Outcomes

Case report

Optimal Management of a Synchronous Diagnosis of Phaeochromocytoma and Colorectal Neoplasia

Original Article

Radical Treatment of Rectal Cancer in Elderly Is Feasible than Feared: Results from a Tertiary Care Centre

Original Article

Squamous Cell and Adenosquamous Carcinoma of Gall Bladder: a Clinicopathological Study of 8 Cases Isolated in 94 Cancers

Letter to the Editor

Tailoring the Best Technique in the Surgical Management of IVC Thrombosis